(1 - 16 von 19
)
BIOTRONIK Announces First Patients Treated in BIOFLOW-II Clinical...
www.finanznachrichten.de
BIOTRONIK announced today the start of an international study comparing the company's ORSIRO sirolimus-eluting coronary stent with Abbott Laboratory's XIENCE
Further reports from the ACC 57th Scientific Session
healthcare-in-europe.com
A five-year study of 516 participants with coronary artery disease showed that patients who reduced their anxiety levels or kept them steady were 60% less...
Trials on newer generation drug-eluting stents in small coronary...
cardiovascularnews.com
George Siontis and Stephan Windecker. A network meta-analysis (published in JACC: Cardiovascular Interventions) of early generation, drug-eluting stents, bare metal stents, drug-coated balloons, and balloon angioplasty indicate that sirolimus-eluting stents are associated with the most favourable ...
sortiert nach Relevanz / Datum